Complete Filing Data
Fermi Inc. reported Stockholders Equity of $1.10 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Fermi Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income Loss | -$486.4M |
| Other Nonoperating Income Expense | -$312.3M |
| Operating Income Loss | -$177.8M |
| Operating Expenses | $177.8M |
| Nonoperating Income Expense | -$308.6M |
| Interest Expense Nonoperating | -$3.7M |
| General And Administrative Expense | $177.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Net Income Loss | -$346.8M | -$6.3M | -$78.0K |
| Other Nonoperating Income Expense | -$309.0M | ||
| Operating Income Loss | -$37.8M | ||
| Operating Expenses | $37.8M | ||
| Nonoperating Income Expense | -$309.0M | ||
| Interest Expense Nonoperating | -$12.0K | ||
| General And Administrative Expense | $37.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stockholders Equity | $1.10B | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $408.5M | $0.00 |
| Repayments Of Notes Payable | $20.0M | |
| Prepaid Expense And Other Assets | $47.8M | |
| Other Liabilities | $9.8M | |
| Operating Lease Right Of Use Asset | $21.7M | |
| Operating Lease Liability | $21.3M | |
| Liabilities And Stockholders Equity | $1.41B | |
| Liabilities | $317.4M | |
| Debt Current | $109.8M | |
| Common Stock Value | $628.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $408.5M | |
| Cash And Cash Equivalents At Carrying Value | $408.5M | |
| Assets | $1.41B | |
| Accounts Payable And Accrued Liabilities Current And Noncurrent | $176.6M | |
| Retained Earnings Accumulated Deficit | -$133.2M | |
| Restricted Cash | ||
| Property Plant And Equipment Net | $935.3M | |
| Preferred Stock Value | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Stockholders Equity | $302.5M | -$1.8M | $420.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $183.0M | ||
| Repayments Of Notes Payable | |||
| Prepaid Expense And Other Assets | $24.4M | ||
| Other Liabilities | $9.7M | ||
| Operating Lease Right Of Use Asset | $24.6M | ||
| Operating Lease Liability | $22.6M | ||
| Liabilities And Stockholders Equity | $502.8M | ||
| Liabilities | $200.3M | ||
| Debt Current | $102.8M | ||
| Common Stock Value | $575.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | |||
| Cash And Cash Equivalents At Carrying Value | $83.7M | ||
| Assets | $502.8M | ||
| Accounts Payable And Accrued Liabilities Current And Noncurrent | $65.1M | ||
| Retained Earnings Accumulated Deficit | |||
| Restricted Cash | $99.3M | ||
| Property Plant And Equipment Net | |||
| Preferred Stock Value |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Share Based Compensation | $3.6K |
| Proceeds From Other Debt | $26.1M |
| Proceeds From Issuance Of Preferred Stock And Preference Stock | $107.6M |
| Proceeds From Issuance Of Debt | $100.0M |
| Proceeds From Convertible Debt | $75.5M |
| Payments To Acquire Property Plant And Equipment | $569.3M |
| Payments Of Stock Issuance Costs | $21.2M |
| Payments Of Debt Issuance Costs | $1.0M |
| Net Cash Provided By Used In Operating Activities | -$34.2M |
| Net Cash Provided By Used In Investing Activities | -$570.3M |
| Net Cash Provided By Used In Financing Activities | $1.01B |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $8.5M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $15.0M |
| Stock Issued During Period Value Share Based Compensation | |
| Proceeds From Payments For Other Financing Activities | $354.0K |
| Proceeds From Issuance Initial Public Offering | $745.6M |
| Payments For Proceeds From Other Investing Activities | $956.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 |
|---|---|
| Share Based Compensation | |
| Proceeds From Other Debt | |
| Proceeds From Issuance Of Preferred Stock And Preference Stock | |
| Proceeds From Issuance Of Debt | |
| Proceeds From Convertible Debt | |
| Payments To Acquire Property Plant And Equipment | |
| Payments Of Stock Issuance Costs | |
| Payments Of Debt Issuance Costs | |
| Net Cash Provided By Used In Operating Activities | |
| Net Cash Provided By Used In Investing Activities | |
| Net Cash Provided By Used In Financing Activities | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | |
| Stock Issued During Period Value Share Based Compensation | $24.8M |
| Proceeds From Payments For Other Financing Activities | |
| Proceeds From Issuance Initial Public Offering | |
| Payments For Proceeds From Other Investing Activities |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 468.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 468.0M |
| Earnings Per Share Diluted | $-1.13 |
| Earnings Per Share Basic | $-1.13 |
| Common Stock Shares Outstanding | 629.8M |
| Common Stock Shares Issued | 629.8M |
| Preferred Stock Shares Authorized | 10.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 |
| Common Stock Shares Authorized | 2.40B |
| Common Stock Par Or Stated Value Per Share | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 |
| Preferred Stock Shares Issued | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 |
|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 466.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 466.5M |
| Earnings Per Share Diluted | $-0.84 |
| Earnings Per Share Basic | $-0.84 |
| Common Stock Shares Outstanding | |
| Common Stock Shares Issued | |
| Preferred Stock Shares Authorized | 10.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 |
| Common Stock Shares Authorized | 2.40B |
| Common Stock Par Or Stated Value Per Share | $0.00 |
| Preferred Stock Shares Outstanding | |
| Preferred Stock Shares Issued |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stock Issued During Period Value New Issues | $977.0K |
| Stock Issued During Period Value Induced Conversion Of Series A And Series B Convertible Notes | $23.7M |
| Stock Issued During Period Value Conversion Of Units | $146.6M |
| Stock Issued During Period Value Conversion Of Convertible Securities | $282.2M |
| Noncash Contribution Expense | $173.8M |
| Change In Fair Value Of Embedded Derivative | $111.6M |
| Additional Paid In Capital | $1.23B |
| Units Issued During Period Value Vesting Of Class B Units Note9 | |
| Stock Issued During Period Value Vesting Of Class B Units | $76.0K |
| Stock Issued During Period Value Sharebased Compensation Expense Related Party | |
| Stock Issued During Period Value Sharebased Charitable Contribution Expense Including Repurchase Of Unvested Class B Units | |
| Stock Issued During Period Value Share Based Charitable Contribution Expense Including Repurchase Of Unvested Class B Units | |
| Stock Issued During Period Value Effect Of The Corporate Conversion | $0.00 |
| Other Noncash Income Expense | -$653.0K |
| Foreign Currency Transaction Gain Loss Unrealized After Tax | -$3.3M |
| Convertible Notes Inducement Expense | $23.7M |
| Construction In Progress Gross |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Stock Issued During Period Value New Issues | $479.0K | $498.0K | |
| Stock Issued During Period Value Induced Conversion Of Series A And Series B Convertible Notes | $23.7M | ||
| Stock Issued During Period Value Conversion Of Units | $146.6M | ||
| Stock Issued During Period Value Conversion Of Convertible Securities | $282.2M | ||
| Noncash Contribution Expense | |||
| Change In Fair Value Of Embedded Derivative | |||
| Additional Paid In Capital | $301.9M | ||
| Units Issued During Period Value Vesting Of Class B Units Note9 | $43.0K | ||
| Stock Issued During Period Value Vesting Of Class B Units | |||
| Stock Issued During Period Value Sharebased Compensation Expense Related Party | $3.6M | ||
| Stock Issued During Period Value Sharebased Charitable Contribution Expense Including Repurchase Of Unvested Class B Units | $173.8M | ||
| Stock Issued During Period Value Share Based Charitable Contribution Expense Including Repurchase Of Unvested Class B Units | $173.8M | ||
| Stock Issued During Period Value Effect Of The Corporate Conversion | |||
| Other Noncash Income Expense | |||
| Foreign Currency Transaction Gain Loss Unrealized After Tax | |||
| Convertible Notes Inducement Expense | |||
| Construction In Progress Gross | $270.7M |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.